SEC Form 4 reporting owner

Groves Regina E

Groves Regina E has filed 3 Form 4 transactions reported between May 14, 2026 and September 11, 2026, as Director of AtriCure, Inc. and a reporting owner of Fulgent Genetics, Inc..

Name as filed: GROVES REGINA E

Open-market buys, 24 mo

None

reported

Open-market sales, 24 mo

$288K

1 lines

Companies

with Form 4 filings

Latest transaction

Sep 11, 2026

transaction date

Roles and reported holdings

ATRCAtriCure, Inc.
May 18, 2026 – Sep 11, 2026
Director
Held directly34,546 sh as of Sep 11, 2026 · Form 4
24 months: $288K sold
FLGTFulgent Genetics, Inc.
May 14, 2026
Reporting owner
No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 3 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

Date	Company	Type	Shares	Price	Value	Owned after	Filing
Sep 11, 2026	ATRCDirector	Open-market saleCode S · direct	5,313	$54.22	$288K@ $54.22	34,546	Form 4
May 18, 2026	ATRCDirector	Grant or awardCode A · direct	6,144	—	—	39,859	Form 4
May 14, 2026	FLGT	Grant or awardCode A · direct	11,117	—	—	28,099	Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.